This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Vistagen Therapeutics, Inc.. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Jack S Hicklin: Innovator in Neurological Therapeutics
Introduction
Jack S Hicklin is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of neurological therapeutics. With a total of six patents to his name, Hicklin has made strides in developing innovative dosage forms and therapeutic uses for L-4-chlorokynurenine.
Latest Patents
Hicklin's latest patents focus on the compositions and therapeutic applications of L-4-chlorokynurenine. These patents detail methods for treating neurological dysfunction, showcasing his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Hicklin has worked with notable companies, including Vistagen Therapeutics, Inc. His work has been instrumental in the development of new therapeutic approaches, particularly in the realm of neurological health.
Collaborations
Hicklin has collaborated with esteemed colleagues such as H Ralph Snodgrass and Allen E Cato, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Jack S Hicklin's work exemplifies the spirit of innovation in the medical field, particularly in neurological therapeutics. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile